C57BL/6J-Tie1em1Kaali/Oulu

Status

Available to order

EMMA IDEM:15969
Citation informationRRID:IMSR_EM:15969 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6J-Tie1em1Kaali/Oulu
Alternative nameTie1R979W (Tie1-RW)
Strain typeEndonuclease-mediated
Allele/Transgene symbolTie1em-R979W
Gene/Transgene symbolTie1

Information from provider

ProviderKari Alitalo
Provider affiliationWihuri Research Institute
Genetic informationUsing the CRISPR/Cas9 technique, four point mutations were generated in exon 18 of the Tie1 gene. Two of the mutations were intended to cause an amino acid substitution at codon 979, changing arginine (Arg) to tryptophan (Trp). The other two mutations were silent with respect to the encoded amino acid residues. These additional mutations were required to prevent the RNP complex from targeting the already modified genomic DNA and to create a new restriction enzyme cutting site, which was utilized for genotyping. Changes in exon 18: Codon 978 (silent mutation): GCC (Ala) → GCA (Ala) → no amino acid change Codon 979 (knock-in mutation): CGA (Arg) → TGG (Trp) → amino acid change Codon 980 (silent mutation): AAT (Asn) → AAC (Asn) → no amino acid change CRISPR technology details: The Alt-R™ S.p. HiFi Cas9 Nuclease V3 was obtained from Integrated DNA Technologies. The Cas9 gene was not inserted into the mouse genome.
Phenotypic informationHomozygous:
Mice homozygous for the mutation die soon after birth. As early as embryonic day 15.5, the homozygous embryos show pronounced nuchal translucency. At E18.5, the embryos are alive but are swollen and exhibit hemorrhage at the tip of the tail and sometimes in other parts of the skin. The embryos display hypoplastic lymphatic vessels, immature collecting vessels, and a lack of valves in the dorsal skin, mesentery, and intestine.

Heterozygous:
Mice heterozygous for the mutation do not display any obvious phenotype.
Breeding historyMicroinjected embryos of C57BL/6J origin were transferred into pseudopregnant females, and pups positive for the knock-in allele were backcrossed to the C57BL/6J strain. The F1 generation was further backcrossed to the C57BL/6J strain eight times.
References
  • Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.;Brouillard Pascal, Murtomäki Aino, Leppänen Veli-Matti, Hyytiäinen Marko, Mestre Sandrine, Potier Lucas, Boon Laurence M, Revencu Nicole, Greene Arin, Anisimov Andrey, Salo Miia H, Hinttala Reetta, Eklund Lauri, Quéré Isabelle, Alitalo Kari, Vikkula Miikka, ;2024;The Journal of clinical investigation;134;; 38820174
Homozygous fertileno
Homozygous viableno
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Oulu, Oulu, Finland

Disease and phenotype information

MGI phenotypes (gene matching)
  • abnormal small intestine morphology / MGI
  • thick pulmonary interalveolar septum / MGI
  • edema / MGI
  • skin edema / MGI
  • abnormal lymphatic vessel morphology / MGI
  • hemorrhage / MGI
  • respiratory failure / MGI
  • postnatal lethality / MGI
  • no abnormal phenotype detected / MGI
  • small heart / MGI
  • abnormal pulmonary alveolus morphology / MGI
  • abnormal heart atrium morphology / MGI
  • abnormal vascular branching morphogenesis / MGI
  • intestinal edema / MGI
  • abnormal vascular endothelial cell development / MGI
  • abnormal lymph circulation / MGI
  • pulmonary edema / MGI
  • abnormal endocardium morphology / MGI
  • lymphatic vessel hyperplasia / MGI
  • dilated vasculature / MGI
  • abnormal renal glomerulus morphology / MGI
  • cardiovascular system phenotype / MGI
  • abnormal vascular endothelial cell morphology / MGI
  • abnormal lymphangiogenesis / MGI
  • neonatal lethality, complete penetrance / MGI
  • perinatal lethality, complete penetrance / MGI
  • lethality throughout fetal growth and development, complete penetrance / MGI
  • prenatal lethality, incomplete penetrance / MGI
  • embryonic lethality during organogenesis, incomplete penetrance / MGI

Literature references

  • Loss-of-function mutations of the TIE1 receptor tyrosine kinase cause late-onset primary lymphedema.;Brouillard Pascal, Murtomäki Aino, Leppänen Veli-Matti, Hyytiäinen Marko, Mestre Sandrine, Potier Lucas, Boon Laurence M, Revencu Nicole, Greene Arin, Anisimov Andrey, Salo Miia H, Hinttala Reetta, Eklund Lauri, Quéré Isabelle, Alitalo Kari, Vikkula Miikka, ;2024;The Journal of clinical investigation;134;; 38820174

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).